Repurposing existing medicines focused on known drug targets is likely to offer a more rapid hope of tackling COVID-19 than developing and manufacturing a vaccine, argue an international team of scientists in the British ...
May 7, 2020
0
457
A purified botanical CBD used to treat mice with a rare form of epilepsy found for the first time that the treatment may reduce premature mortality, according to a new study.
Apr 24, 2020
0
354
A Griffith University pharmacologist has played a key role in the world-first discovery of an eight-molecule snake venom toxin with the potential to become a diagnostic tool or new drug for neurological and neurodegenerative ...
Feb 11, 2020
1
121
Lawmakers across the United States continue to debate the safety of kratom, an opioid-containing plant that has been listed as a "drug of concern" by the U.S. Food and Drug Administration. Kratom is sold over the counter ...
Nov 13, 2019
0
2
In an editorial published in the British Journal of Pharmacology (BJP), the Editor-in-Chief and Senior Editors have recommended that all future studies published in the journal should formally address sex as an experimental ...
Aug 23, 2019
0
3
A new molecule, EPB-53, could help fight type 2 diabetes and non-alcoholic fatty liver disease, according to a new study led by the team of Manuel Vázquez-Carrera, from the Faculty of Pharmacy and Food Sciences and the Institute ...
Apr 10, 2019
0
4
Bee venom and its major component, melittin, may be effective treatments for atopic dermatitis (or eczema), according to a British Journal of Pharmacology study.
Sep 6, 2018
0
0
(HealthDay)—Illnesses that lack exact testing methods can be difficult to diagnose, treat and live with, both physically and emotionally. Chronic fatigue syndrome, or CFS, is one such disease. Until recently, it was very ...
Jul 18, 2018
0
0
Previous research has shown that cannabinoids can help lessen side effects of anti-cancer therapies. Now a new British Journal of Pharmacology review has examined their potential for the direct treatment of cancer.
Jul 18, 2018
0
2
A new British Journal of Pharmacology review examines how phosphodiesterase-5 (PDE5) inhibitors, which were originally approved to treat erectile dysfunction, are finding clinical uses for a wide variety of conditions.
Apr 19, 2018
0
2
